Combining Nivolumab With Radiation Shows Promise in Melanoma Patients With Brain Mets

Combining nivolumab (Opdivo) with radiation therapy may provide better disease control and prolong overall survival (OS) in patients with melanoma whose disease has metastasized to the brain, compared with standard current treatment, according to a recent retrospective analysis.

OncLive